- Investing Ideas
- /
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
17
0 new
Companies with a Value score of at least 3, ordered by Value score
17 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MRK | AR$23,425.00 | 0.5% | 10.7% | AR$252.2b | AR$30,653.91 | PE20.5x | E16.0% | 3.3% | ||
GILD | AR$27,200.00 | -0.4% | 37.6% | AR$117.3b | AR$29,242.73 | PE910.1x | E40.7% | 3.3% | ||
BMYD | US$20.60 | 0% | n/a | US$117.0b | US$21.75 | PS2.5x | E48.7% | 4.3% | ||
BMY | AR$22,350.00 | -0.4% | 35.8% | AR$117.0b | AR$24,283.79 | PS2.4x | E48.7% | 4.4% | ||
BIIB | AR$13,725.00 | 1.7% | -28.5% | AR$22.0b | AR$22,299.39 | PE13.5x | E13.6% | n/a | ||
MRKD | US$20.20 | -2.7% | -12.9% | US$252.2b | US$26.43 | PE20.5x | E16.0% | 3.3% | ||
BIIBD | US$11.45 | 0% | -50.2% | US$22.0b | US$18.60 | PE13.5x | E13.6% | n/a | ||
NVSD | US$25.00 | 0% | n/a | US$177.6b | US$29.25 | PE16.7x | E7.0% | 3.6% | ||
GSKD | US$8.64 | 0.5% | n/a | US$54.8b | US$11.69 | PE21.8x | E23.2% | 4.3% | ||
NVS | AR$29,125.00 | 1.0% | 20.5% | AR$177.3b | AR$34,123.26 | PE16.7x | E7.0% | 3.7% | ||
GILDD | US$24.60 | 0.4% | 2.5% | US$117.3b | US$25.86 | PE930.8x | E40.7% | 3.3% | ||
ROSE | AR$122.00 | 5.4% | 90.6% | AR$5.3b | n/a | PE5.2x | n/a | n/a | ||
GSK | AR$9,990.00 | 0.6% | 10.9% | AR$54.4b | AR$13,606.16 | PE21.7x | E23.2% | 4.3% | ||
AMGND | US$8.50 | 0% | 10.6% | US$139.4b | US$10.57 | PE33x | E15.8% | 3.7% | ||
TMOD | US$28.50 | 0% | n/a | US$201.2b | US$35.20 | PE32.8x | E11.5% | 0.3% | ||
AMGN | AR$10,300.00 | 0.7% | 10.4% | AR$141.2b | AR$12,807.64 | PE33x | E18.5% | 3.7% | ||
TMO | AR$28,150.00 | 1.7% | 20.3% | AR$201.2b | AR$35,255.54 | PE32.3x | E11.5% | 0.3% |
Page 1 of 1